Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(2)
•••
Comment by jakethesnake2on Nov 17, 2015 9:47pm
306 Views
Post# 24299386

RE:jakethesnake2: you're saying SEDI reported/recorded

RE:jakethesnake2: you're saying SEDI reported/recordedgibbonsj
I've seen it done a hundred times, so here it is


Insider name: Booth, Jonathan  
Insider's Relationship to Issuer: 5 - Senior Officer of Issuer  
Ceased to be Insider: Not applicable  
Security designation: Common Shares  
        2741014 2015-11-17 2015-11-17 Indirect Ownership :
Trust Account 		10 - Acquisition or disposition in the public market +25,000 2.2090 USD 25,000                
   
Insider name: Mesburis, Paul  
Insider's Relationship to Issuer: 4 - Director of Issuer  
Ceased to be Insider: Not applicable  
Security designation: Common Shares  
        2740994 2015-11-17 2015-11-17 Direct Ownership : 90 - Change in the nature of ownership -10,706     224,201                
   
        2740998 2015-11-17 2015-11-17 Indirect Ownership :
TFSA 		90 - Change in the nature of ownership +10,706     33,306  
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities